Eyenovia share price today

(EYEN)

Eyenovia share price is $0.09 & ₹7.70 as on 30 Dec 2024, 20.32 hrs IST

$0.09

Market is closed - opens 8 PM, 30 Dec 2024

View live Eyenovia share price in Dollar and Rupees. Guide to invest in Eyenovia from India. Also see the sentimental analysis on Indian investors investing in Eyenovia. Get details on the Indian mutual funds that are investing in Eyenovia. Get Analyst recommendations and forecasts along with all the Eyenovia's financials.

Eyenovia share price movements

Today's Low: $0.09
Today's High: $0.10
$0.09
1.67%
Downside
Day's Volatility :6.84%
Upside
5.26%
52 Weeks Low: $0.08
52 Weeks High: $2.57
$0.09
14.44%
Downside
52 Weeks Volatility :97.0%
Upside
96.5%

Eyenovia Returns

Period	Eyenovia Inc	Index (Russel 2000)
3 Months	-81.77%	0.0%
6 Months	-86.12%	0.0%
1 Year	-95.12%	0.0%
3 Years	-97.65%	-21.3%

Eyenovia Key Statistics

in dollars & INR

Previous Close	$0.094
Open	$0.092
Today's High	$0.095
Today's Low	$0.0885
Market Capitalization	$10.5M
Today's Volume	$13.4M
52 Week High	$2.57
52 Week Low	$0.077
Revenue TTM	$31.4K
EBITDA	$-34.8M
Earnings Per Share (EPS)	$-0.69
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-914.66%

How to invest in Eyenovia from India?

It is very easy for Indian residents to invest directly in Eyenovia from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Eyenovia stock in both Indian Rupees (INR) and US Dollars (USD). Search for Eyenovia or EYEN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Eyenovia or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Eyenovia shares which would translate to 9.504 fractional shares of Eyenovia as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Eyenovia, in just a few clicks!

Returns in Eyenovia for Indian investors in Rupees

Investment Value

₹1,00,000

Eyenovia investment value today

Current value as on today

₹7,458

Returns

₹92,542

(-92.54%)

Returns from Eyenovia Stock

₹95,337 (-95.34%)

Dollar Returns

₹2,795 (+2.79%)

Indian investors sentiment towards Eyenovia

-37.99%

Period: Sep 30, 2024 to Dec 29, 2025. Change in 30 Days versus previous period

Investment in Eyenovia from India has reduced in the last 30 days as on Dec 30, 2025. -37.99% less purchase transactions for Eyenovia in the last 30 days versus the previous period.

157%

Period: Sep 30, 2024 to Dec 29, 2025. Change in 30 Days versus previous period

Search volume for Eyenovia on INDmoney from India has grown in the last 30 days as on Dec 30, 2025. 157% more investors are searching Eyenovia in the last 30 days versus the previous period.

Global Institutional Holdings in Eyenovia

Armistice Capital, LLC
8.94%
Vanguard Group Inc
1.97%
Geode Capital Management, LLC
0.58%
Lasry Marc
0.57%
Millennium Management LLC
0.41%
Jane Street Group LLC
0.24%

Analyst Recommendation on Eyenovia

Buy

90%Buy

10%Hold

0%Sell

Based on 10 Wall street analysts offering stock ratings for Eyenovia(by analysts ranked 0 to 5 stars)

Based on 10 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Eyenovia

What analysts predicted

Upside of 2122.22%

Current:

$0.09

Target:

$2.00

Insights on Eyenovia

Price Movement
In the last 7 days, EYEN stock has moved up by 11.5%
EYEN vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 24.3% return, outperforming this stock by 119.8%
EYEN vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 39.1% return, outperforming this stock by 136.6%
Price to Sales
ForEYEN every $1 of sales, investors are willing to pay $94.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.4 for every $1 of sales.

Eyenovia Technicals Summary

Sell

Neutral

Buy

Eyenovia is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Eyenovia Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Eyenovia Inc	2.39%	-86.12%	-95.12%	-97.65%	-97.82%
Regeneron Pharmaceuticals, Inc.	-6.55%	-32.6%	-21.28%	12.81%	90.81%
Biontech Se	-2.77%	44.55%	1.43%	-55.8%	195.97%
Alnylam Pharmaceuticals, Inc.	-5.94%	-2.2%	22.08%	40.33%	105.82%
Vertex Pharmaceuticals Incorporated	-12.23%	-13.26%	-0.52%	86.14%	86.27%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Eyenovia Inc	NA	NA	NA	-0.62	-9.15	-0.93	NA	0.2
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.07	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Eyenovia Inc	Buy	$10.5M	-97.82%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	90.81%	17.67	33.61%
Biontech Se	Buy	$27.3B	195.97%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.3B	105.82%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.8B	86.27%	32.84	-4.51%

About Eyenovia

eyenovia, inc. (nasdaq: eyen) is a specialty biopharmaceutical company building a portfolio of next generation topical eye treatments based on its proprietary delivery and formulation platform for microdosing. eyenovia’s pipeline is currently focused on the late-stage development of microdosed medications for myopia progression, presbyopia, mydriasis and other eye diseases.

Organization	Eyenovia
Employees	57
CEO	Mr. Michael M. Rowe
Industry	Health Technology

Management People of Eyenovia

Name	Title
Mr. Michael M. Rowe	CEO, President & Director
Dr. Tsontcho Ianchulev M.D., M.P.H., MPH	Co-Founder & Executive Director
Mr. Bren Kern	COO & Corporate VP
Mr. John P. Gandolfo CPA	Secretary
Mr. Andrew D. Jones	CFO, Secretary & Treasurer
Mr. Tony Cardinale	Vice President of Sales
Mr. Norbert Lowe	Senior Vice President of Commercial Operations
Alexander Lobo	Investor Contact

Important FAQs about investing in Eyenovia from India :

What is Eyenovia share price today?

Eyenovia share price today stands at $0.09, Open: $0.09 ; Previous Close: $0.09 ; High: $0.10 ; Low: $0.09 ; 52 Week High: $2.57 ; 52 Week Low: $0.08. The stock opens at $0.09, after a previous close of $0.09. The stock reached a daily high of $0.10 and a low of $0.09, with a 52-week high of $2.57 and a 52-week low of $0.08.

Can Indians buy Eyenovia shares?

Yes, Indians can invest in the Eyenovia (EYEN) from India.

With INDmoney, you can buy Eyenovia at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Eyenovia at zero transaction cost.

How can I buy Eyenovia shares from India?

It is very easy to buy Eyenovia from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Eyenovia be purchased?

Yes, you can buy fractional shares of Eyenovia with INDmoney app.

What are the documents required to start investing in Eyenovia stocks?

To start investing in Eyenovia, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.